Systemic Sclerosis (Scleroderma) and Malignancy

Japanese Journal of Clinical Immunology
doi 10.2177/jsci.27.389
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japan Society for Clinical Immunology

Related search

Systemic Sclerosis (Scleroderma). Introduction.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1991English

The Articular Manifestations of Progressive Systemic Sclerosis (Scleroderma).

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1982English

Systemic Sclerosis and Malignancy: A Review of Current Data

Journal of Clinical Medicine Research
2016English

Initial Predictors of Survival in Patients With Systemic Sclerosis (Scleroderma).

Keio Journal of Medicine
Medicine
1992English

Systemic Sclerosis Complicated With Localized Scleroderma-Like Lesions Induced by Köbner Phenomenon

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2018English

Thrombotic Thrombocytopenic Purpura With Severe Hypertension in a Patient With Systemic Sclerosis Sine Scleroderma and Polymyositis

Internal Medicine
Internal MedicineMedicine
2011English

Pediatric Scleroderma: Systemic or Localized Forms

Pediatric Clinics of North America
Child HealthPediatricsPerinatology
2012English

Scleroderma-Polymyositis Overlap Syndrome Versus Idiopathic Polymyositis and Systemic Sclerosis: A Descriptive Study on Clinical Features and Myopathology

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Antiubiquitin Antibody in Localised and Systemic Scleroderma.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy